Figure 1From: How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design – a reanalysis of 4 trials Development of intermediate outcome hazard ratio over time in trials showing evidence of effect on primary outcome. 95% CIs for the hazard ratio (shaded area) and the critical value for assessing whether to continue randomising further patients are given.Back to article page